Skip to main content
. 2019 May 20;55(5):174. doi: 10.3390/medicina55050174

Table 3.

Comparison of laboratory results between obstructive sleep apnea syndrome (OSAS) patients with (HOMA-IR ≥ 2) and without (HOMA-IR < 2) insulin resistance.

OSAS Patients With
HOMA IR < 2
n = 34
OSAS Patients With
HOMA IR ≥ 2
n = 58
p
FEV1 (% predicted) 96.5 ± 21.3 90.1 ± 21 0.201
FVC (% predicted) 95 ± 16.4 85.8 ± 20.9 0.052
FEV1/FVC (%) 83.2 (78–88.6) 82 (73.2–96.8) 0.485
pO2 (mmHg) 81.4 ± 12.7 75.3 ± 11.1 0.022
pCO2 (mmHg) 40 (39–42.4) 40.7 (38.6–44.8) 0.809
Glucose (mg/dL) 84 ± 11 104 ± 17 < 0.001
HOMA–IR 1.1 (0.5–1.6) 5.5 (3.2–15.1) < 0.001
Cholesterol (mg/dL) 207 ± 48 208 ± 39 0.952
Triglycerides (mg/dL) 108 (84–177) 167 (115–227) 0.010
LDL-C (mg/dL) 107 (80–148) 109 (100–150) 0.338
HDL-C (mg/dL) 48 ± 11 46 ± 13 0.405
CRP (mg/dL) 0.25 (0.09–0.63) 0.46 (0.14–0.96) 0.199
25(OH)D (ng/mL) 26.7 ± 12.2 19.3 ± 11.5 0.005

CRP: C-reactive protein, FEV1: Forced expiratory volume in 1st sec, FVC: Forced vital capacity, HDL-C: High density lipoprotein-cholesterol, HOMA-IR: Homeostatic Model Assessment of Insulin Resistance, LDL-C: Low density lipoprotein-cholesterol, pCO2: Carbon dioxide partial pressure, pO2: Oxygen partial pressure, 25(OH)D: 25-hydroxyvitamin D.